IAIM
VKTX icon

International Assets Investment Management’s Viking Therapeutics VKTX Stock Holding History

International Assets Investment Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Buy
6,057
+130
+2% +$4.2K 0.01% 819
2026
Q1 		$195K Hold
5,927
– – 0.01% 815
2025
Q4 		$209K Sell
5,927
-4,687
-44% -$166K 0.01% 794
2025
Q3 		$283K Hold
10,614
– – 0.02% 628
2025
Q2 		$281K Sell
10,614
-16,970
-62% -$447K 0.02% 633
2025
Q1 		$666K Buy
27,584
+9,308
+51% +$294K 0.06% 332
2024
Q4 		$752K Sell
18,276
-985,757
-98% -$56.2M 0.06% 295
2024
Q3 		$15.9K Buy
1,004,033
+994,801
+10,776% +$58.4M 0.04% 323
2024
Q2 		$489K Buy
9,232
+2,756
+43% +$181K 0.05% 370
2024
Q1 		$515K Sell
6,476
-13,492
-68% -$600K 0.05% 363
2023
Q4 		$372K Sell
19,968
-2,450
-11% -$32K 0.05% 416
2023
Q3 		$245K Sell
22,418
-8,820
-28% -$126K 0.03% 438
2023
Q2 		$506K Buy
31,238
+31,135
+30,228% +$652K 0.07% 271
2023
Q1 		$1.72K Buy
+103
New +$1.06K ﹤0.01% 1009

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

International Assets Investment Management's VKTX Position: Q2 2026 in Review

International Assets Investment Management increased its Viking Therapeutics (VKTX) stake by 2.2% in Q2 2026, buying an estimated $4.2K and bringing the position to 6,057 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #819.

International Assets Investment Management first reported a position in VKTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $752K in Q4 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • International Assets Investment Management held 6,057 shares of Viking Therapeutics worth $227K as of Q2 2026.
  • International Assets Investment Management bought 130 Viking Therapeutics shares in Q2 2026, an estimated $4.2K.
  • Viking Therapeutics made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #819 holding.
  • International Assets Investment Management first reported a position in Viking Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • International Assets Investment Management's Viking Therapeutics position peaked at $752K in Q4 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.